Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction

Cited by papers we hold 12

• Exosome-Based Drug Delivery: Translation from Bench to Clinic · 2023
  No notice
• Exosomal targeting and its potential clinical application · 2022
  No notice
• Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy · 2022
  No notice
• A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021 · 2021
  No notice
• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021
  No notice
• Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases · 2021
  No notice
• Engineering exosomes for targeted drug delivery · 2021
  No notice
• Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets · 2021
  No notice
• Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine · 2021
  No notice
• HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis · 2020
  No notice
• Exosome in Cardiovascular Diseases: A Complex World Full of Hope · 2019
  No notice
• Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.